PROVIDER PROFILE · NPI 1649327016
Laura JohnstonMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
153
Unique beneficiaries
—
Total services
530
Distinct HCPCS
4
Medicare payment
$60K
Peer benchmark
Total Medicare services vs. 9 Hematopoietic Cell Transplantation and Cellular Therapy providers in CA — top quintile (cohort median 271).
PRESCRIBING · PART D · 2024
Total Rx claims
114
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
5
Brand share
57.9%
Top prescribed drugs
Acyclovir36 claims
Ruxolitinib Phosphate34 claims
Belumosudil Mesylate16 claims
Sulfamethoxazole/Trimethoprim16 claims
Gabapentin12 claims
QUALITY · MIPS · 2024
Final MIPS score
88.5
Quality
87.1
Cost
69.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.57%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Laura Johnston's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Lori Muffly Hematopoietic Cell Transplantation and Cellular Therapy · Stanford, CA | 18 | 229 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE